Global group taps U.S. biotechs to speed work on Nipah vaccine
LONDON (Reuters) - A global coalition set up a year ago to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed at least 11 people in India.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Biotechnology | Brain | Epidemics | Epidemiology | Health | India Health | Neurology | Nipah Virus | Vaccines